Assessing the Cost-Effectiveness of Three-Monthly Paliperidone Palmitate Versus its Prior Monthly Formulation for the Management of Schizophrenia in the UK Setting
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1262
https://www.valueinhealthjournal.com/article/S1098-3015(18)31565-1/fulltext
Title :
Assessing the Cost-Effectiveness of Three-Monthly Paliperidone Palmitate Versus its Prior Monthly Formulation for the Management of Schizophrenia in the UK Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31565-1&doi=10.1016/j.jval.2018.04.1262
First page :
Section Title :
Open access? :
No
Section Order :
520